Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Differences in height and laboratory findings of patients before and after asfotase alfa (N = 13). Variables | Baseline median [IQR] | Last visit median (IQR) | P-value a: Vitamin D (nmol/L) (n = 9) | 77.37 [23.5, 94.5] | 43 [20.5, 77.75] | 0.314
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Age-specific reference ranges were applied for ALP: 130 to 260 IU/L for children aged 3 to <10 years, 130 to 340 IU/L for those aged 10 to <14 years, 30 to 180 IU/L for adolescents aged 14 to 18 years, and 30 to 130 IU/L for adults (>18 years).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Phenotype and genotype of hypophosphatasia cases in Saudi Arabia: multi-center case cohort
Study design awaiting verification · Frontiers in Genetics · 2026
Original publication title
Phenotype and genotype of hypophosphatasia cases in Saudi Arabia: multi-center case cohort
Copyright © 2026 Alsagheir, Mcrabi, Alquayt, Alhuthil, Alawi, Faqeih, Alabdullatif, Homyani, AlJohany, AlOtaibi, Rabea, AlSayed and Al-Hamed.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Hypophosphatasia (HPP) is a rare inherited metabolic disease caused by mutations in the ALPL gene. The disease is heterogeneous, complicating its diagnosis and delaying optimal management, leading to severe or lethal outcomes such as failure to thrive, fragility fractures, bone deformities, delayed motor development, respiratory failure, seizures, and premature death. However, no epidemiological studies on the incidence of HPP in Saudi Arabia have been identified until now. Therefore, the study aimed to describe the phenotype and genotype of Saudi patients with HPP.
Source: IntroductionAbstract: What methods does the paper describe?
This retrospective multicenter case series included six centers in Saudi Arabia. Paediatrics and adult patients with clinically and genetically confirmed HPP were included between January 2014 and May 2024. Demographic and clinical information, including medical history, clinical, biochemical, genetic, and management data, was collected retrospectively from medical records and summarized descriptively. Additionally, whole-exome sequencing or ALPL next-generation sequencing (NGS) was performed. Furthermore, pre: and post-analysis for patients who received asfotase alfa was performed using the Wilcoxon signed-rank test.
Source: MethodsAbstract: Results
The study included 19 HPP cases, of whom 68.4% were male. There were five patients with perinatal onset (26.3%), 13 with infantile onset (68.4%), and one with childhood onset (5.3%) of HPP. About 78.9% of patients indicated a family history of HPP; consanguinity was observed in nearly all parents of cases. Bone deformities were observed in all patients, including skull (78.5%), limb (100%), spinal (49.9%), and dental abnormalities (57.9%). Complications such as craniosynostosis (78.5%), nephrocalcinosis (26.3%), kyphoscoliosis (49.9%), and convulsions (26.3%) were also documented, with 4 (21.05%) deaths.
Thirteen (68.4%) of our patients received asfotase alfa. All cases tested positive for ALPL variants, with the most common being c.293C>T (p.Ser98Phe) and c.977G>T (p.Gly326Val), both of which were novel and not previously reported.
Source: ResultsAbstract: Conclusion
Our study highlights HPP’s diverse phenotypes and genotypes in Saudi Arabia, revealing distinct ALPL mutations. We identified a high prevalence of consanguinity and family histories of HPP. Treatment with asfotase alfa was generally effective and safe.
Source: ConclusionAuthors’ abstract
Introduction
Hypophosphatasia (HPP) is a rare inherited metabolic disease caused by mutations in the ALPL gene. The disease is heterogeneous, complicating its diagnosis and delaying optimal management, leading to severe or lethal outcomes such as failure to thrive, fragility fractures, bone deformities, delayed motor development, respiratory failure, seizures, and premature death. However, no epidemiological studies on the incidence of HPP in Saudi Arabia have been identified until now. Therefore, the study aimed to describe the phenotype and genotype of Saudi patients with HPP.
Methods
This retrospective multicenter case series included six centers in Saudi Arabia. Paediatrics and adult patients with clinically and genetically confirmed HPP were included between January 2014 and May 2024. Demographic and clinical information, including medical history, clinical, biochemical, genetic, and management data, was collected retrospectively from medical records and summarized descriptively. Additionally, whole-exome sequencing or ALPL next-generation sequencing (NGS) was performed. Furthermore, pre: and post-analysis for patients who received asfotase alfa was performed using the Wilcoxon signed-rank test.
Results
The study included 19 HPP cases, of whom 68.4% were male. There were five patients with perinatal onset (26.3%), 13 with infantile onset (68.4%), and one with childhood onset (5.3%) of HPP. About 78.9% of patients indicated a family history of HPP; consanguinity was observed in nearly all parents of cases. Bone deformities were observed in all patients, including skull (78.5%), limb (100%), spinal (49.9%), and dental abnormalities (57.9%). Complications such as craniosynostosis (78.5%), nephrocalcinosis (26.3%), kyphoscoliosis (49.9%), and convulsions (26.3%) were also documented, with 4 (21.05%) deaths.
Thirteen (68.4%) of our patients received asfotase alfa. All cases tested positive for ALPL variants, with the most common being c.293C>T (p.Ser98Phe) and c.977G>T (p.Gly326Val), both of which were novel and not previously reported.
Conclusion
Our study highlights HPP’s diverse phenotypes and genotypes in Saudi Arabia, revealing distinct ALPL mutations. We identified a high prevalence of consanguinity and family histories of HPP. Treatment with asfotase alfa was generally effective and safe.
Publication and source details
Original title: Phenotype and genotype of hypophosphatasia cases in Saudi Arabia: multi-center case cohort
Afaf Alsagheir; Ali Mcrabi; Meshari Alquayt; Raghad Alhuthil; Afnan Alawi; Eissa Faqeih; Abrar Turki Alabdullatif; Doua Al Homyani; Amal AlJohany; Mariam AlOtaibi; Magdy Rabea; Hassan AlSayed; Mohamed H. Al-Hamed
Frontiers in Genetics · 2026
* Correspondence: Afaf Alsagheir, ASagheir@kfshrc.edu.sa Copyright © 2026 Alsagheir, Mcrabi, Alquayt, Alhuthil, Alawi, Faqeih, Alabdullatif, Homyani, AlJohany, AlOtaibi, Rabea, AlSayed and Al-Hamed.2026Alsagheir, Mcrabi, Alquayt, Alhuthil, Alawi, Faqeih, Alabdullatif, Homyani, AlJohany, AlOtaibi, Rabea, AlSayed and Al-Hamedhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was partially supported by KFMC Research Centre [Intramural Research Fund; Demography of Recessive Diseases in KSA; Grant #019-052].Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:31:55.984475+00:00
DOI: 10.3389/fgene.2025.1715818 · PMC12835560